They cover peptide basics, the preclinical evidence for BPC-157 and TB-500, mechanisms like angiogenesis and tissue repair, the lack of robust human trials, sourcing risks, regulatory bans, and the gap between anecdotal reports and scientific certainty
C.ZamockyM.LazzarottoF.Margis-PinheiroGoing ForwardM
In 2023, the FDA designated BPC-157 as a Category 2 bulk drug substance, meaning it cannot be compounded by licensed pharmacies due to insufficient human safety data
NADPH-dependent and -independent disulfide reductase systems
Precursors to Glutathione: Certain supplements, such as N-acetylcysteine (NAC) and alpha-lipoic acid, are glutathione precursors